Mayne Pharma Group Ltd (MYX) — Cash Flow Reinvestment Rate

Latest as of June 2025: 0.17x

Mayne Pharma Group Ltd (MYX) has a Cash Flow Reinvestment Rate of 0.17x as of June 2025, reinvesting AU$5.40 Million (capex AU$5.40 Million ) from operating cash flow of AU$31.98 Million. Explore MYX capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.17x
(Capex + Investments) / Operating CF

Total Reinvested

AU$5.40 Million
Capex + Investments

Operating Cash Flow

AU$31.98 Million
AUD

Capital Expenditures

AU$5.40 Million
AUD

Mayne Pharma Group Ltd Cash Flow Reinvestment Rate (2010–2025)

Historical reinvestment intensity for Mayne Pharma Group Ltd across 12 annual periods. Also explore Mayne Pharma Group Ltd asset portfolio for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Mayne Pharma Group Ltd (2010–2025)

Year-by-year capital reinvestment analysis for Mayne Pharma Group Ltd. For live market cap and broader valuation context, see Mayne Pharma Group Ltd market capitalisation.

Year Reinvestment Rate Total Reinvested (AUD) Operating CF Capex YoY Change
2025 0.70x AU$12.28 Million AU$17.47 Million AU$12.28 Million ▼ -55.3%
2021 1.57x AU$74.34 Million AU$47.26 Million AU$25.10 Million ▲ +52.4%
2020 1.03x AU$102.99 Million AU$99.78 Million AU$47.12 Million ▲ +6.2%
2019 0.97x AU$103.60 Million AU$106.61 Million AU$11.91 Million ▼ -31.6%
2018 1.42x AU$172.53 Million AU$121.50 Million AU$54.18 Million ▼ -33.0%
2016 2.12x AU$113.39 Million AU$53.50 Million AU$29.59 Million ▲ +1038.3%
2015 0.19x AU$4.17 Million AU$22.42 Million AU$4.17 Million ▲ +15.8%
2014 0.16x AU$4.20 Million AU$26.14 Million AU$4.20 Million ▼ -94.8%
2013 3.08x AU$21.06 Million AU$6.84 Million AU$21.06 Million ▲ +1517.0%
2012 0.19x AU$2.55 Million AU$13.39 Million AU$2.55 Million ▼ -63.1%
2011 0.51x AU$2.10 Million AU$4.09 Million AU$2.10 Million ▲ +1225.0%
2010 0.04x AU$398.56K AU$10.26 Million AU$398.56K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow